股票 › RVMD
革命医药 RVMD
美股市值排名 #525
$192.28 +$14.63 (+8.24%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $194.38 +1.09%
开盘$184.87
昨收$177.65
当日区间$181.27 – $195.02
成交量4.50M
市值$41.59B
市盈率（TTM）–
股息率–
财报
财报日平均波动±3.1%近16次财报
收涨次数6 / 1638% 的概率
最佳反应+11.3%
最差反应-5.7%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 5 Aug 2026 | After Market | ±8.4% | +0.26% | 符合区间 |
| 2026/Q1 | 6 May 2026 | After Market | ±5.5% | -5.67% | 超出定价预期 |
| 2025/Q4 | 25 Feb 2026 | After Market | ±11.6% | -1.06% | 符合区间 |
| 2025/Q3 | 5 Nov 2025 | After Market | ±8.6% | +3.44% | 符合区间 |
| 2025/Q2 | 6 Aug 2025 | After Market | ±11.1% | -4.69% | 符合区间 |
| 2025/Q1 | 7 May 2025 | After Market | ±12.4% | +11.29% | 符合区间 |
| 2024/Q4 | 26 Feb 2025 | After Market | ±8.6% | -3.51% | 符合区间 |
| 2024/Q3 | 6 Nov 2024 | After Market | ±11.9% | -0.54% | 符合区间 |
| 2024/Q2 | 7 Aug 2024 | After Market | ±13.3% | -0.69% | 符合区间 |
| 2024/Q1 | 8 May 2024 | After Market | ±17.2% | -2.24% | 符合区间 |
| 2023/Q4 | 26 Feb 2024 | After Market | ±12.9% | +0.79% | 符合区间 |
| 2023/Q3 | 6 Nov 2023 | After Market | ±19.2% | -0.23% | 符合区间 |
| 2023/Q2 | 8 Aug 2023 | After Market | ±13.1% | -1.82% | 符合区间 |
| 2023/Q1 | 8 May 2023 | After Market | ±13.6% | +3.07% | 符合区间 |
| 2022/Q4 | 27 Feb 2023 | After Market | ±18.3% | +9.81% | 符合区间 |
| 2022/Q3 | 7 Nov 2022 | After Market | ±15.2% | -0.61% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$505.13M-90.8% YoY
净利润-$644.37M-160.1% YoY
摊薄每股收益-$3.06-133.6% YoY
自由现金流-$745.31M-225.2% YoY
经营现金流-$741.48M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
净资产收益率-79.1%
资产收益率-52.4%
投入资本回报率-68.9%
流动比率11.38
负债/资产比率39.7%
现金及投资$3.94B
总负债$625.18M
净现金（净负债）$3.31B
暂无评论——快来第一个聊聊 RVMD。
登录后参与讨论。